Metacel Pharms Llc Drug Patent Portfolio
Metacel Pharms Llc owns 1 orange book drug protected by 1 US patent Given below is the list of Metacel Pharms Llc's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10610502 | Oral baclofen solutions | 30 Aug, 2039 | Active |
Latest Legal Activities on Metacel Pharms Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Metacel Pharms Llc.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Nov, 2023 | US10610502 |
Surcharge for late Payment, Small Entity | 08 Nov, 2023 | US10610502 |
Application ready for PDX access by participating foreign offices
Critical
| 07 Apr, 2020 | US10610502 |
Recordation of Patent Grant Mailed
Critical
| 07 Apr, 2020 | US10610502 |
Patent Issue Date Used in PTA Calculation
Critical
| 07 Apr, 2020 | US10610502 |
Email Notification
Critical
| 19 Mar, 2020 | US10610502 |
Issue Notification Mailed
Critical
| 18 Mar, 2020 | US10610502 |
Printer Rush- No mailing | 16 Mar, 2020 | US10610502 |
Email Notification
Critical
| 16 Mar, 2020 | US10610502 |
Mail Response to 312 Amendment (PTO-271)
Critical
| 16 Mar, 2020 | US10610502 |
Dispatch to FDC | 13 Mar, 2020 | US10610502 |
Application Is Considered Ready for Issue
Critical
| 12 Mar, 2020 | US10610502 |
Response to Amendment under Rule 312
Critical
| 12 Mar, 2020 | US10610502 |
Pubs Case Remand to TC
Critical
| 10 Mar, 2020 | US10610502 |
Issue Fee Payment Verified
Critical
| 26 Feb, 2020 | US10610502 |
Metacel Pharms Llc's Family Patents

Metacel Pharms Llc Drug List
Given below is the complete list of Metacel Pharms Llc's drugs and the patents protecting them.
1. Ozobax
Ozobax is protected by 1 patent, which is still active. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10610502 | Oral baclofen solutions |
30 Aug, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ozobax's drug page